1. Vaccine research boomed with COVID — but it’s still a one-country show Summary: This systematic mapping and scientometric analysis (PRISMA 2020) searched PubMed, Scopus, and Web of Science for studies (January...
Summary This open-label, first-in-human phase 1 dose-escalation trial evaluated the DNA vaccine pEVAC-PS, a computationally designed pan-sarbecovirus candidate delivered intradermally by needle-free PharmaJet Tropis in...
The World Health Organization has warned that the Zika R&D frenzy may not culminate in a vaccine in time for the current outbreak, but Sanofi Chief Scientific Officer Gary Nabel won’t take that for an answer...